Posted On: 01/25/2014 11:43:12 AM
Post# of 63824
$EAPH breakout / short consolidation $0.015
Shares Outstanding 224,712,997 a/o Oct 01, 2013
Float 198,255,000 a/o Oct 01, 2013
Authorized Shares 250,000,000 a/o Oct 01, 2013
Par Value 0.0001
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives Marketwired (Thu, Jan 16)
LAM PHARMACEUTICAL CORP Financials EDGAR Online Financials (Fri, Dec 13)
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra" Marketwired (Wed, Dec 11)
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising Marketwired (Wed, Nov 6)
Shares Outstanding 224,712,997 a/o Oct 01, 2013
Float 198,255,000 a/o Oct 01, 2013
Authorized Shares 250,000,000 a/o Oct 01, 2013
Par Value 0.0001
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives Marketwired (Thu, Jan 16)
LAM PHARMACEUTICAL CORP Financials EDGAR Online Financials (Fri, Dec 13)
Easton Pharmaceuticals Provides Update on Initiatives Towards Its Cancer Drug "Xilive" and Its Mexican Government Regulatory Filing Submission for "Viorra" Marketwired (Wed, Dec 11)
Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising Marketwired (Wed, Nov 6)
(0)
(0)
